About our ads
Advertise with us
NewsOK Local Stocks
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
NewsOK Local Stocks
Streaming Delayed Price
5:20 PM EDT, Jul 20, 2018
Add to My Watchlist
Price and Volume
3081.79 - 3125.68
2607.92 - 3358.68
BIOMARIN PHARM RG
SEATTLE GENETICS RG
ALNYLAM PHARMA RG
Merck touts a 60% price cut, but the drug is outdated and on the way out
Today 15:55 EDT
The hepatitis C drug’s sales have declined since newer, better treatments hit the market.
Notable Friday Option Activity: MBI, CBRL, ILMN
Today 15:37 EDT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in MBIA Inc. (MBI), where a total of 5,718 contracts have traded so far, representing...
Market News Video
UPDATE 1-Agios Pharmaceuticals leukemia drug gets U.S. approval
Today 12:18 EDT
Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation.
Reuters: Company News
Analysts See 10% Upside For AMCA
Today 10:38 EDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Biogen to Host Investor Webcast to Discuss Alzheimer’s Disease Portfolio on July 25, 2018
Today 8:39 EDT
Biogen (Nasdaq:BIIB) today announced it will host a live webcast providing a Q&A session related to its Alzheimer’s disease investigational therapies on Wednesday, July 25, 2018. The live webcast will...
GlobeNewswire News Releases
Jim Cramer Advises His Viewers On BlackRock, Target And More
Today 7:30 EDT
On CNBC's "Mad Money Lightning Round", Jim Cramer said Biogen Inc (NASDAQ: BIIB) could double if it meets its endpoints ...
3 Top Healthcare Stocks to Buy in July
Today 6:15 EDT
New products, bigger markets, and market-moving news could cause shares in these three companies to rally.
Seattle Genetics Clears Key Benchmark, Hitting 90-Plus RS Rating
Today 3:00 EDT
A Relative Strength Rating upgrade for Seattle Genetics shows improving technical performance.
Investor's Business Daily
Data & News supplied by
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions